NYSE · Stock
REGN
Regeneron Pharmaceuticals, Inc.
783.29
Market closed · last price 15h ago
Last 24 hours
Bid
783.02
Ask
783.57
Day High
793.40
Day Low
781.16
REGN key statistics
1 week
-2.19%
1 month
+12.98%
52w high
841.42
52w low
540.32
Avg daily range
+1.88%
History from
13 Aug 2025
Highs and lows are taken from 261 daily bars — the high was set on 04 Sept 2026 and the low on 13 Oct 2025. REGN is quoted to 5 decimal places, minimum tick 0.00001, spread at last quote 0.55000, quoted in USD on NYSE, sourced from MetaTrader 5 (Broker 1).
REGN daily history
| Date | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| 11 Sept 2026 | 793.15 | 794.08 | 781.50 | 782.95 | -1.29% |
| 09 Sept 2026 | 802.95 | 808.28 | 796.75 | 806.52 | +0.44% |
| 08 Sept 2026 | 809.25 | 821.35 | 808.34 | 813.35 | +0.51% |
| 04 Sept 2026 | 836.71 | 841.42 | 827.90 | 828.12 | -1.03% |
| 01 Sept 2026 | 810.86 | 823.78 | 806.74 | 822.79 | +1.47% |
| 31 Aug 2026 | 787.92 | 800.62 | 783.67 | 800.50 | +1.60% |
| 28 Aug 2026 | 796.87 | 799.30 | 789.23 | 793.41 | -0.43% |
| 27 Aug 2026 | 817.05 | 817.24 | 808.72 | 809.27 | -0.95% |
| 26 Aug 2026 | 829.50 | 829.50 | 816.51 | 818.65 | -1.31% |
| 20 Aug 2026 | 835.21 | 840.66 | 827.57 | 827.66 | -0.90% |
REGN API access
Regeneron Pharmaceuticals, Inc. prices are available over REST and WebSocket with no API key and no signup. Rate limit is 15,000 requests per minute per IP.
curl
curl "https://biquote.io/api/REGN"
Python
import requests
r = requests.get("https://biquote.io/api/REGN")
tick = r.json()
print(tick["mid"], tick["dayDiffPercent"])JavaScript
const r = await fetch("https://biquote.io/api/REGN");
const tick = await r.json();
console.log(tick.mid, tick.dayDiffPercent);WebSocket
// SignalR hub — pushes every tick for REGN
const conn = new signalR.HubConnectionBuilder()
.withUrl("https://biquote.io/hubs/tick")
.build();
conn.on("ReceiveTick", t => console.log(t.symbol, t.mid));
await conn.start();
await conn.invoke("Subscribe", "REGN");Also available for REGN: daily candles, hourly candles · full API documentation
News about REGN
- Here’s Why The Fund Sold Regeneron Pharmaceuticals (REGN)Yahoo Finance·2d ago
- Why Is Regeneron Pharmaceuticals (REGN) Facing A New Investor Lawsuit?simplywall.st·1d ago
- REGN SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP RemindsGlobeNewswire·21h ago
- Regeneron Pharmaceuticals (NASDAQ:REGN): A Credible Value Stock With a Meaningful DiscountChartMill·2d ago
- Levi & Korsinsky Reminds Regeneron Pharmaceuticals Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of September 14, 2026 - REGNPR Newswire·2d ago
- 1 WEEK REGN INVESTOR DEADLINE: Regeneron Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit Before September 14, 2026 DeadlineTMX Newsfile·4d ago